The Potential Roles of Von Willebrand Factor and Neutrophil Extracellular Traps in the Natural History of Hypertrophic and Hypertensive Cardiomyopathy

Overview

Journal Thromb Res

Date 2020 May 28

PMID 32460175

Citations 1

Authors

Richard C Becker

A Phillip Owens 3rd

Sakthivel Sadayappan

Affiliations

Soon will be listed here.

Abstract

Inflammation is often applied broadly to human disease. Despite its general familiarity, inflammation is highly complex. There are numerous injurious, immune and infectious determinants, functional elements and signaling pathways, ranging from genetic to epigenetic, environmental, racial, molecular and cellular that participate in disease onset and progression, phenotypic heterogeneity, and treatment selection and response. In addition, inflammation can be tissue and organ specific, adding a layer of complexity to achieving a detailed and translatable understanding of its role in health and disease. The following review takes a close look at inflammation in the context of two common heart diseases, hypertrophic cardiomyopathy and hypertensive cardiomyopathy.

Citing Articles

The Immune and Inflammatory Basis of Acquired Pediatric Cardiac Disease.

Jui E, Singampalli K, Shani K, Ning Y, Connell J, Birla R Front Cardiovasc Med. 2021; 8:701224.

PMID: 34386532 PMC: 8353076. DOI: 10.3389/fcvm.2021.701224.

References

Urbina E, Khoury P, Bazzano L, Burns T, Daniels S, Dwyer T . Relation of Blood Pressure in Childhood to Self-Reported Hypertension in Adulthood. Hypertension. 2019; 73(6):1224-1230. PMC: 6510248. DOI: 10.1161/HYPERTENSIONAHA.118.12334. View

Nandi S, Sproul E, Nellenbach K, Erb M, Gaffney L, Freytes D . Platelet-like particles dynamically stiffen fibrin matrices and improve wound healing outcomes. Biomater Sci. 2019; 7(2):669-682. PMC: 6385160. DOI: 10.1039/c8bm01201f. View

Szatmary P, Huang W, Criddle D, Tepikin A, Sutton R . Biology, role and therapeutic potential of circulating histones in acute inflammatory disorders. J Cell Mol Med. 2018; 22(10):4617-4629. PMC: 6156248. DOI: 10.1111/jcmm.13797. View

Wimmer R, Leopoldi A, Aichinger M, Kerjaschki D, Penninger J . Generation of blood vessel organoids from human pluripotent stem cells. Nat Protoc. 2019; 14(11):3082-3100. DOI: 10.1038/s41596-019-0213-z. View

Euler M, Hoffmann M . The double-edged role of neutrophil extracellular traps in inflammation. Biochem Soc Trans. 2019; 47(6):1921-1930. DOI: 10.1042/BST20190629. View

Thornton P, McColl B, Greenhalgh A, Denes A, Allan S, Rothwell N . Platelet interleukin-1alpha drives cerebrovascular inflammation. Blood. 2010; 115(17):3632-9. DOI: 10.1182/blood-2009-11-252643. View

Oehmcke S, Morgelin M, Herwald H . Activation of the human contact system on neutrophil extracellular traps. J Innate Immun. 2010; 1(3):225-30. PMC: 6951039. DOI: 10.1159/000203700. View

Michels A, Swystun L, Mewburn J, Albanez S, Lillicrap D . Investigating von Willebrand Factor Pathophysiology Using a Flow Chamber Model of von Willebrand Factor-platelet String Formation. J Vis Exp. 2017; (126). PMC: 5614259. DOI: 10.3791/55917. View

He D, Ye M, Zhang L, Jiang B . Prognostic significance of late gadolinium enhancement on cardiac magnetic resonance in patients with hypertrophic cardiomyopathy. Heart Lung. 2017; 47(2):122-126. DOI: 10.1016/j.hrtlng.2017.10.008. View

10.

Maron B, Maron M, Maron B, Loscalzo J . Moving Beyond the Sarcomere to Explain Heterogeneity in Hypertrophic Cardiomyopathy: JACC Review Topic of the Week. J Am Coll Cardiol. 2019; 73(15):1978-1986. PMC: 6550351. DOI: 10.1016/j.jacc.2019.01.061. View

11.

Rhee A, Lavine K . New Approaches to Target Inflammation in Heart Failure: Harnessing Insights from Studies of Immune Cell Diversity. Annu Rev Physiol. 2019; 82:1-20. PMC: 7202684. DOI: 10.1146/annurev-physiol-021119-034412. View

12.

Schlossarek S, Englmann D, Sultan K, Sauer M, Eschenhagen T, Carrier L . Defective proteolytic systems in Mybpc3-targeted mice with cardiac hypertrophy. Basic Res Cardiol. 2011; 107(1):235. DOI: 10.1007/s00395-011-0235-3. View

13.

Zolkova J, Sokol J, Simurda T, Vadelova L, Snahnicanova Z, Loderer D . Genetic Background of von Willebrand Disease: History, Current State, and Future Perspectives. Semin Thromb Hemost. 2019; 46(4):484-500. DOI: 10.1055/s-0039-3402430. View

14.

Holthenrich A, Drexler H, Chehab T, Nass J, Gerke V . Proximity proteomics of endothelial Weibel-Palade bodies identifies novel regulator of von Willebrand factor secretion. Blood. 2019; 134(12):979-982. PMC: 8270391. DOI: 10.1182/blood.2019000786. View

15.

Bravo P, Di Carli M, Dorbala S . Role of PET to evaluate coronary microvascular dysfunction in non-ischemic cardiomyopathies. Heart Fail Rev. 2017; 22(4):455-464. PMC: 6214157. DOI: 10.1007/s10741-017-9628-1. View

16.

Urbina E, Kimball T, Khoury P, Daniels S, Dolan L . Increased arterial stiffness is found in adolescents with obesity or obesity-related type 2 diabetes mellitus. J Hypertens. 2010; 28(8):1692-8. PMC: 2909014. DOI: 10.1097/HJH.0b013e32833a6132. View

17.

Sadler J . Biochemistry and genetics of von Willebrand factor. Annu Rev Biochem. 1998; 67:395-424. DOI: 10.1146/annurev.biochem.67.1.395. View

18.

Becker R, Owens 3rd A, Sadayappan S . Tissue-level inflammation and ventricular remodeling in hypertrophic cardiomyopathy. J Thromb Thrombolysis. 2020; 49(2):177-183. PMC: 7001758. DOI: 10.1007/s11239-019-02026-1. View

19.

Marian A, Braunwald E . Hypertrophic Cardiomyopathy: Genetics, Pathogenesis, Clinical Manifestations, Diagnosis, and Therapy. Circ Res. 2017; 121(7):749-770. PMC: 5654557. DOI: 10.1161/CIRCRESAHA.117.311059. View

20.

Rohde J, Roopnarine O, Thomas D, Muretta J . Mavacamten stabilizes an autoinhibited state of two-headed cardiac myosin. Proc Natl Acad Sci U S A. 2018; 115(32):E7486-E7494. PMC: 6094135. DOI: 10.1073/pnas.1720342115. View